Intimation of Schedule of Analyst/Institutional Investor meetings

Ref: 37/SE/LC/2026-27 Date: August 24, 2026 Scrip Code BSE: 544122 NSE: ENTERO ISIN: INE010601016 Head, Listing Compliance Department Head, Listing Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Dalal Street, Exchange Plaza, Plot No. C/1. G Block, Mumbai - 400001 Bandra -Kurla Complex, Bandra (East), Mumbai- 400051 Dear Sir/Madam, Subject: Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Pursuant to Regulation 30(6) read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the officials of the Company will be attending the Investor Conference as per below details: Type of Date Time Organized by Mode Location Interaction September 03:00 P.M. 1x1 / Group Elara Capital Physical Mumbai 02, 2026 Onwards Meeting Discussions will be based on publicly available information. No unpublished price-sensitive information (UPSI) is intended to be discussed during the interactions. Kindly note that changes may happen due to exigencies on the part of Participants / Company. This is for your information and records Yours Faithfully, For Entero Healthcare Solutions Limited Sanu Kapoor Vice President- Group General Counsel, Company Secretary & Compliance Officer